Shanti Swarup Bhatnagar Prize 2012

• Biological sciences
  • Shantanu Chowdhury of the Institute of Genomics and Integrative Biology
  • Suman Kumar Dhar of the Special Centre for Molecular Medicine at the Jawaharlal Nehru University

• Chemical sciences
  • Govindsamy Mugesh of the Indian Institute of Science, Bangalore (IISc)
  • Gangadhar J Sanjayan of the CSIR National Chemical Laboratory, Pune

• Engineering sciences
  • Ravishankar Narayanan of IISc
  • Y Shanthi Pavan of Indian Institute of Technology – Madras

• Mathematical sciences
  • Siva Ramachandran Athreya
  • Debashish Goswami of the Indian Statistical Institute

• Medical sciences
  • Sandip Basu of the Radiation Medicine Centre at Bhabha Atomic Research Centre

• Physical sciences
  • Arindam Ghosh of IISc
  • Krishnendu Sengupta of the Indian Association for the Cultivation of Science

Clinical Trial Deaths: Top Countries and New Drug Guinea Pig Patients

India is just one of many developing countries used by leading Western pharmaceutical companies, which spent £40bn in 2010 on research and development. Globally, it is estimated around 120,000 trials are taking place in 178 countries.

India

1. 668 deaths were reported in 2010
2. 438 in 2011
3. 211 deaths till June 2012

In a written reply to a question in the Lok Sabha, Minister for Health and Family Welfare Ghulam Nabi Azad said a total of 1,954 persons died from 2009 till June 2012 due to “serious adverse events of death” in clinical trials.

1. South Korea – 2,861
2. China – 2,520
3. Taiwan – 2,367
4. Brazil – 2,521
5. Russia – 1,776
6. India – 1,727
7. Mexico – 1,488
8. South Africa – 1,346
9. Argentina – 1,223
10. Puerto Rico – 1,231
11. Thailand – 958
12. Turkey – 893
13. Romania (876)
14. Ukraine – 722
15. Chile – 663
16. Peru (494)
17. Phillipines – 487
18. Iran – 387
19. Egypt – 274
20. Uganda – 163
21. Malawi (61)
22. Kazakhstan (15)